Engage with experts and peers on all aspects of cardiac catheterization.
Richard A. Lange, MD, MBA and L. David Hillis, MD
The current standard of care for individuals undergoing carotid arterial stenting (CAS) entails the use of an embolic protection device (EPD) to minimize the risk for embolic stroke. At present, the only FDA-approved EPD is a filter that is placed distal to the stenosis (i.e., it is advanced across the lesion) before stenting. In a recently completed randomized trial, a proximal balloon occlusion device…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Tags: carotid artery stenting, distal embolic filter, embolic protection device, PROFI, proximal balloon occlusion
- 0 Recommendations
- |
- 3 Comments
Richard A. Lange, MD, MBA and L. David Hillis, MD
The Gravina Island Bridge (also known as The Bridge to Nowhere) was a proposed bridge to replace the ferry that currently connects Ketchikan, Alaska (population, 14,000) to the Ketchikan International Airport on Gravina Island (population, 50) at a projected cost of $398 million. The bridge was to have been nearly as long as the Golden Gate…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Tags: BRIDGE trial, cangrelor, Cardiac surgery, thienopyridines, VerifyNOW
- 1 Recommendations
- |
- 2 Comments
Richard A. Lange, MD, MBA and L. David Hillis, MD
In a 2009 NEJM article, the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) study group published 1 to 5 (mean, 2.7) year follow-up data for almost 48,000 registry patients who received a bare metal (BMS) or drug-eluting coronary stent (DES) between 2003 and 2006, concluding that the two are associated with a similar long-term incidence…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
- 1 Recommendations
- |
- 0 Comments
